Thoracic and Robotic Surgery
Our surgeons remain at the forefront of thoracic and robotic surgery, continually striving to improve patient care through innovation, dedication and advanced medical practices.
Advancements in robotics
2024 Outcomes
Overview
Thoracic and robotic surgery continue to grow with a significant increase in the utilization of robotic platforms. Our growth has enhanced our capabilities and solidified our status as one of the busiest robotic centers in the world. The Plano location is a leading center that proctors other institutions in robotic thoracic and cardiac surgery techniques. Our commitment to excellence ensures that we provide our patients with the highest quality of care backed by the latest technological advancements and a highly skilled medical team.
Accomplishments
- Strong growth in robotic surgeries: Plano has seen a significant 36% growth over the past two years.
- Expansion of minimally invasive robotic technologies: We have successfully expanded the use of minimally invasive robotic technologies for foregut surgery, improving patient outcomes and decreasing the length of hospital stays.
- Excellent patient outcomes: Our lung cancer surgery population has achieved a remarkable 0% mortality rate.
- Increased thoracic surgery volume: We continue to see growth in thoracic surgeries, particularly for esophageal cancer and other foregut surgeries.
thoracic volume
total thoracic volume: 365
278
ROBOTIC
87
NON-ROBOTIC
Date range for all data is June 2023-May 2024.
“We embrace a commitment that possesses an in-depth understanding of pathophysiology, diagnosis and treatment of thoracic and foregut disease while developing a broad range of specialized treatment plans for our lung and foregut population.”
Andrew Nguyen, MD
Regional Medical Director and Chief of Thoracic Surgery
THORACIC OUTCOMES - FY24
| STS THORACIC PROCEDURE FY24 | LOBECTOMY | SEGMENTECTOMY RESECTION |
|---|---|---|
| Volume | 49 | 5 |
| PFT complete | 100% (95.53%) | 100% (93.37%) |
| Unexpected invasive procedures | 0% (3.13%) | 0% (1.77%) |
| Mortality | 0% (0.57%) | 0% (0.17%) |
% = Plano performance (%) = STS GT registry average
Innovations
Baylor Scott & White The Heart Hospital – Plano was the first cardiovascular specialty hospital in North Texas to offer robotic heart and thoracic surgery, and our teams continue to push the field forward.
- Focus on collaboration: We have established a yearly Foregut Cancer Symposium that focuses on diagnosing and treating cancers in the esophagus, stomach and upper intestines. This multidisciplinary event involves thoracic surgery, surgical oncology, gastroenterology, medical oncology and radiation oncology.
- Use of CYTALUX®: A thoracic surgeon on our medical staff has initiated the use of this FDA-approved prescription medication administered intravenously to adult patients suspected of needing lung cancer surgery. This innovative medication enhances the visualization of lung cancer lesions during surgery.
- Advancements in robotic technologies: The Plano location continues to grow in robotic technologies, and state-of-the-art robotic platforms are actively being investigated to advance future healthcare for our community.
Quality awards 2024
Achievements placing us among the elite
Denton
Denton: 3 Stars in 1 Category
Previous
Next